Organon launched a campaign for its contraceptive implant, Nexplanon, that plays on the themes of BookTok’s popular “romantasy” genre.

Pharmaceutical company Organon (NYSE:OGN) reported in Q1 CY2025, but sales fell by 6.7% year on year to $1.51 billion. Its non-GAAP profit of $1.02 per share was 14.2% above analysts’ consensus ...

Shares of Organon & Co. fell to a record low on Thursday after a series of analyst downgrades and price target cuts followed ...

Recent 13F Filing and Investment Strategies. Warning! GuruFocus has detected 3 Warning Sign with C. Kahn Brothers (Trades, ...

Organon's Q1 2025 earnings report showed significant declines across key financial metrics, leading to a drastic 30% drop in ...

Organon (OGN) stock dropped 13% after the company's Q1 results indicated its plans to cut dividends to $0.02/share amid a focus on debt reduction. Read more here.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Organon (NYSE:OGN) saw significant volatility last month with a 30% decline in its share price, coinciding with the company's announcement of decreased earnings and a reduction in its dividend payout.

Global healthcare company Organon recently hosted a forum in the Philippines to address pressing concerns in women’s health, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...